Concord Wealth Partners Takeda Pharmaceutical CO LTD Transaction History

Concord Wealth Partners

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$13.12 - $15.03 $10,666 - $12,219	-813 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$13.54 - $15.35 $8,137 - $9,225	-601 Reduced 42.5%	813 $12,000
Q4 2021 Jan 21, 2022	BUY	$13.17 - $16.4 $9,693 - $12,070	736 Added 108.55%	1,414 $19,000
Q3 2021 Nov 09, 2021	SELL	$16.3 - $17.26 $14,784 - $15,654	-907 Reduced 57.22%	678 $11,000
Q2 2021 Jul 29, 2021	SELL	$16.55 - $18.64 $2,101 - $2,367	-127 Reduced 7.42%	1,585 $27,000

Q1 2021 May 13, 2021	BUY	$16.71 - $19.9 $10,911 - $12,994	653 Added 61.66%	1,712 $31,000
Q4 2020 Feb 16, 2021	BUY	$15.39 - $18.97 $16,298 - $20,089	1,059 New	1,059 $19,000

340

76M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.